Inhaled Zanamivir vs Oral Oseltamivir to Prevent Influenza-related Hospitalization or Death: A Nationwide Population-based Quasi-experimental Study
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Journal Volume
75
Journal Issue
8
Pages
1273
Date Issued
2022-10-12
Author(s)
Abstract
Meta-analyses of individual patient data from randomized, controlled trials show that early oseltamivir treatment for influenza cut the risk of pneumonia and hospitalization by 44% and 63%, respectively. However, data on the effectiveness of inhaled zanamivir in preventing hospitalization and death are lacking.
Subjects
complications; effectiveness; influenza; oseltamivir; zanamivir
Publisher
OXFORD UNIV PRESS INC
Type
journal article